HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.

Abstract
Lecithin-cholesterol acyltransferase deficiency is frequently associated with hypertriglyceridemia (HTG) in animal models and humans. We investigated the mechanism of HTG in the ldlr-/- x lcat-/- (double knockout (dko)) mice using the ldlr-/- x lcat+/+ (knock-out (ko)) littermates as control. Mean fasting triglyceride (TG) levels in the dko mice were elevated 1.75-fold compared with their controls (p < 0.002). Both the very low density lipoprotein and the low density lipoprotein/intermediate density lipoprotein fractions separated by fast protein liquid chromatography were TG-enriched in the dko mice. In vitro lipolysis assay revealed that the dko mouse very low density lipoprotein (d < 1.019 g/ml) fraction separated by ultracentrifugation was a more efficient substrate for lipolysis by exogenous bovine lipoprotein lipase. Post-heparin lipoprotein lipase activity was reduced by 61% in the dko mice. Hepatic TG production rate, determined after intravenous Triton WR1339 injection, was increased 8-fold in the dko mice. Hepatic mRNA levels of sterol regulatory element binding protein-1 (srebp-1) and its target genes acetyl-CoA carboxylase-1 (acc-1), fatty acid synthase (fas), and stearoyl-CoA desaturase-1 (scd-1) were significantly elevated in the dko mice compared with the ko control. The hepatic mRNA levels of LXRalpha (lxralpha) and its target genes including angiopoietin-like protein 3 (angptl-3) in the dko mice were unchanged. Fasting glucose and insulin levels were reduced by 31 and 42%, respectively in the dko mice, in conjunction with a 49% reduction in hepatic pepck-1 mRNA (p = 0.014). Both the HTG and the improved fasting glucose phenotype seen in the dko mice are at least in part attributable to an up-regulation of the hepatic srebp-1c gene.
AuthorsDominic S Ng, Chunhui Xie, Graham F Maguire, Xianghong Zhu, Francisca Ugwu, Eric Lam, Philip W Connelly
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 279 Issue 9 Pg. 7636-42 (Feb 27 2004) ISSN: 0021-9258 [Print] United States
PMID14668345 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • CCAAT-Enhancer-Binding Proteins
  • DNA-Binding Proteins
  • Fatty Acids, Nonesterified
  • Insulin
  • Lipids
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Liver X Receptors
  • NR1H3 protein, human
  • Nr1h3 protein, mouse
  • Orphan Nuclear Receptors
  • RNA, Messenger
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, LDL
  • Srebf1 protein, mouse
  • Sterol Regulatory Element Binding Protein 1
  • Transcription Factors
  • Triglycerides
  • Cholesterol
  • Phosphatidylcholine-Sterol O-Acyltransferase
  • Fatty Acid Synthases
  • Acetyl-CoA Carboxylase
Topics
  • Acetyl-CoA Carboxylase (genetics)
  • Animals
  • Blood Glucose (analysis)
  • CCAAT-Enhancer-Binding Proteins (genetics)
  • Cholesterol (blood)
  • DNA-Binding Proteins (genetics)
  • Fasting
  • Fatty Acid Synthases (genetics)
  • Fatty Acids, Nonesterified (metabolism)
  • Hypertriglyceridemia (enzymology)
  • Insulin (blood)
  • Lecithin Cholesterol Acyltransferase Deficiency (blood)
  • Lipids (blood)
  • Lipoproteins, HDL (blood)
  • Lipoproteins, LDL (blood)
  • Lipoproteins, VLDL (blood, metabolism)
  • Liver (chemistry, metabolism)
  • Liver X Receptors
  • Mice
  • Mice, Knockout
  • Orphan Nuclear Receptors
  • Phosphatidylcholine-Sterol O-Acyltransferase (genetics, physiology)
  • RNA, Messenger (analysis)
  • Receptors, Cytoplasmic and Nuclear (genetics)
  • Receptors, LDL (deficiency, genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sterol Regulatory Element Binding Protein 1
  • Transcription Factors
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: